HAEMONETICS CORPORATION (NYSE:HAE) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
HAEMONETICS CORPORATION (NYSE:HAE) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
(b) Departure of Named Executive Officer
Byron Selman, President, Global Markets, is leaving Haemonetics Corporation (the “Company”) effective May 5, 2017. Mr. Selman joined the Company in 2012 as President, North America and has served as President, Global Markets since April 2015.
Haemonetics is grateful for Mr. Selman’s many and significant contributions during his time at the Company and extends its best wishes to him for success in his future endeavors.
About HAEMONETICS CORPORATION (NYSE:HAE)
Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company’s segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection. HAEMONETICS CORPORATION (NYSE:HAE) Recent Trading Information
HAEMONETICS CORPORATION (NYSE:HAE) closed its last trading session up +0.86 at 43.20 with 762,795 shares trading hands.
Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company’s segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection. HAEMONETICS CORPORATION (NYSE:HAE) Recent Trading Information
HAEMONETICS CORPORATION (NYSE:HAE) closed its last trading session up +0.86 at 43.20 with 762,795 shares trading hands.
